These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

790 related articles for article (PubMed ID: 34824200)

  • 21. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toll-like receptors in sepsis: a tale still being told.
    Souza HP; Lima-Salgado T; da Cruz Neto LM
    Endocr Metab Immune Disord Drug Targets; 2010 Sep; 10(3):285-91. PubMed ID: 20509842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advancing cell-based therapy in sepsis: An anesthesia outlook.
    Ye H; Zou X; Fang X
    Chin Med J (Engl); 2024 Jul; 137(13):1522-1534. PubMed ID: 38708689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Host innate immune responses to microbial pathogens.
    Delaloye J; Calandra T
    Curr Vasc Pharmacol; 2013 Mar; 11(2):123-32. PubMed ID: 23506491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using innate immunity to characterize the host response to microbial invasion in severe sepsis.
    Warner EA; Moldawer LL
    Future Microbiol; 2008 Apr; 3(2):177-89. PubMed ID: 18366338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Research progress on the role of histone modification in sepsis].
    Ge F; Lu J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Sep; 35(9):995-998. PubMed ID: 37803962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Automated monitoring compared to standard care for the early detection of sepsis in critically ill patients.
    Warttig S; Alderson P; Evans DJ; Lewis SR; Kourbeti IS; Smith AF
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012404. PubMed ID: 29938790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis.
    Castellheim A; Brekke OL; Espevik T; Harboe M; Mollnes TE
    Scand J Immunol; 2009 Jun; 69(6):479-91. PubMed ID: 19439008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating Histones in Sepsis: Potential Outcome Predictors and Therapeutic Targets.
    Li Y; Wan D; Luo X; Song T; Wang Y; Yu Q; Jiang L; Liao R; Zhao W; Su B
    Front Immunol; 2021; 12():650184. PubMed ID: 33868288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pathogenesis and potential therapeutic targets in sepsis.
    Zhang W; Jiang H; Wu G; Huang P; Wang H; An H; Liu S; Zhang W
    MedComm (2020); 2023 Dec; 4(6):e418. PubMed ID: 38020710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pathophysiological basis of surgery-linked sepsis].
    Vollmar B
    Chirurg; 2011 Mar; 82(3):199-207. PubMed ID: 21249327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PD-1 signaling pathway in sepsis: Does it have a future?
    Chen R; Zhou L
    Clin Immunol; 2021 Aug; 229():108742. PubMed ID: 33905818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Damage-Associated Molecular Patterns As Double-Edged Swords in Sepsis.
    Zhou M; Aziz M; Wang P
    Antioxid Redox Signal; 2021 Nov; 35(15):1308-1323. PubMed ID: 33587003
    [No Abstract]   [Full Text] [Related]  

  • 34. Hemadsorption.
    Cutuli SL; Grieco DL; De Pascale G; Antonelli M
    Curr Opin Anaesthesiol; 2021 Apr; 34(2):113-118. PubMed ID: 33470661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.
    Patil NK; Bohannon JK; Sherwood ER
    Pharmacol Res; 2016 Sep; 111():688-702. PubMed ID: 27468649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Toll-like receptor responses for sepsis pathogenesis.
    Weighardt H; Holzmann B
    Immunobiology; 2007; 212(9-10):715-22. PubMed ID: 18086373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis of sepsis: current concepts and emerging therapies.
    Lei MG; Gao JJ; Morrison DC; Qureshi N
    Mo Med; 2003; 100(5):524-9. PubMed ID: 14601445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The End of "One Size Fits All" Sepsis Therapies: Toward an Individualized Approach.
    Vincent JL; van der Poll T; Marshall JC
    Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unraveling the Multifaceted Role of Glutathione in Sepsis: A Comprehensive Review.
    Tandon R; Tandon A
    Cureus; 2024 Mar; 16(3):e56896. PubMed ID: 38659506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of LPS-Activated Endothelial Subpopulations With Distinct Inflammatory Phenotypes and Regulatory Signaling Mechanisms.
    Dayang EZ; Plantinga J; Ter Ellen B; van Meurs M; Molema G; Moser J
    Front Immunol; 2019; 10():1169. PubMed ID: 31178871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.